Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T19780 |
2,2′-Dipyridyl disulfide
2,2'-Dipyridyl disulfide,OPSS,2,2'-二硫二吡啶,Aldrithiol 2,Orthopyridyl disulfide |
Others | Others |
2,2′-Dipyridyl disulfide (Aldrithiol 2) 是肽化学中的常用试剂,是测定巯基的有用试剂,常用于氧化还原缩合以形成肽键或用于偶联反应以形成二硫键连接的异二聚体。 | |||
T25372 |
EMD57033
EMD-57033,(+)-EMD 57033,EMD 57033 |
Calcium Channel; Carbonic Anhydrase | Membrane transporter/Ion channel; Metabolism |
EMD57033是一种心脏肌钙蛋白C(cTnC)激活剂,是一种显性的Ca2+增敏剂。EMD57033通过与心脏/慢速骨骼肌钙蛋白C 异构体结合从而发挥促进心脏收缩的功能。 | |||
T78870 |
TWIK-1/TREK-1-IN-3
|
Potassium Channel | Membrane transporter/Ion channel |
TWIK-1/TREK-1-IN-3 是一种具有选择性和有效性的钾通道 TREK-1 抑制剂,对含有双孔域钾(K2p)通道的TREK-1同二聚体和TWIK-1/TREK-1异二聚体有抑制作用。TWIK-1/TREK-1-IN-3 具有抗抑郁活性,可用于研究抑郁症。 | |||
T32107 |
HX-603
HX 603 |
||
HX-603 is a selectivity agonist of RXR that inhibits the activation of RAR-RXR heterodimers as well as RXR homodimers. | |||
T78868 | TWIK-1/TREK-1-IN-1 | Potassium Channel | Membrane transporter/Ion channel |
TWIK-1/TREK-1-IN-1 (compound 2a) 是一种针对 TWIK 相关钾通道 (Potassium Channel) TREK-1 的抑制剂,有效抑制 TREK-1 的双孔域钾 (K2p) 通道,阻止其二聚化形成 TREK-1 同二聚体和 TWIK-1/TREK-1 异二聚体。作为抗抑郁治疗的潜在靶点,TWIK-1/TREK-1-IN-3 对 TREK-1 同二聚体和 TWIK-1/TREK-1 异二聚体表现出相当的选择性,IC50s 分别是 9.36 μM 和 14.6 μM,显示出抗抑郁样活性。 | |||
T61401 |
3-(3-Phenoxybenzyl)amino-β-carboline
|
||
3-(3-Phenoxybenzyl)amino-β-carboline is a highly effective tubulin inhibitor, selectively degrading αβ-tubulin heterodimers. It induces cell cycle arrest and apoptosis in the G2/M phase. Additionally, 3-(3-Phenoxybenzyl)amino-β-carboline displays notable anticancer activity [1]. | |||
T38460 |
SN52
|
||
SN52 is a powerful, competitive, and cell-permeable inhibitor of NF-κB2. It is a variant of the SN50 peptide. SN52 effectively prevents the nuclear translocation of p52-RelB heterodimers, exhibiting a robust radiosensitization effect on prostate cancer cells. This compound holds significant potential for cancer research purposes. | |||
T15748 |
LG100754
UVI 2112 |
PPAR | DNA Damage/DNA Repair; Metabolism |
LG100754 (UVI 2112)是一种通过RXR 发挥作用的胰岛素增敏剂。LG100754是RXR 二聚体调节剂。LG100754是RXR:RXR 同二聚体拮抗剂,以及RXR:PPARα和RXR:PPPARγ异二聚体的激动剂。 |